152 related articles for article (PubMed ID: 35465837)
1. Family with sequence similarity 46 member a confers chemo-resistance to ovarian carcinoma via TGF-β/Smad2 signaling.
Liang S; Liu Y; He J; Gao T; Li L; He S
Bioengineered; 2022 Apr; 13(4):10629-10639. PubMed ID: 35465837
[TBL] [Abstract][Full Text] [Related]
2. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
3. LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.
Gao Y; Shan N; Zhao C; Wang Y; Xu F; Li J; Yu X; Gao L; Yi Z
Int J Clin Exp Pathol; 2015; 8(5):4923-32. PubMed ID: 26191185
[TBL] [Abstract][Full Text] [Related]
4. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
Kou B; Liu W; Tang X; Kou Q
Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
[TBL] [Abstract][Full Text] [Related]
5. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.
He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H
J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336
[TBL] [Abstract][Full Text] [Related]
6. KLF8 is activated by TGF-β1 via Smad2 and contributes to ovarian cancer progression.
Cherukunnath A; Davargaon RS; Ashraf R; Kamdar U; Srivastava AK; Tripathi PP; Chatterjee N; Kumar S
J Cell Biochem; 2022 May; 123(5):921-934. PubMed ID: 35293014
[TBL] [Abstract][Full Text] [Related]
7. BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-beta treatment.
Pils D; Wittinger M; Petz M; Gugerell A; Gregor W; Alfanz A; Horvat R; Braicu EI; Sehouli J; Zeillinger R; Mikulits W; Krainer M
Gynecol Oncol; 2010 May; 117(2):189-97. PubMed ID: 20189233
[TBL] [Abstract][Full Text] [Related]
8. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
[TBL] [Abstract][Full Text] [Related]
9. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
Yamamura S; Matsumura N; Mandai M; Huang Z; Oura T; Baba T; Hamanishi J; Yamaguchi K; Kang HS; Okamoto T; Abiko K; Mori S; Murphy SK; Konishi I
Int J Cancer; 2012 Jan; 130(1):20-8. PubMed ID: 21503873
[TBL] [Abstract][Full Text] [Related]
10. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β stimulates human ovarian cancer cell migration by up-regulating connexin43 expression via Smad2/3 signaling.
Qiu X; Cheng JC; Zhao J; Chang HM; Leung PC
Cell Signal; 2015 Oct; 27(10):1956-62. PubMed ID: 26186970
[TBL] [Abstract][Full Text] [Related]
12. Human ortholog of Drosophila Melted impedes SMAD2 release from TGF-β receptor I to inhibit TGF-β signaling.
Shathasivam P; Kollara A; Ringuette MJ; Virtanen C; Wrana JL; Brown TJ
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3000-9. PubMed ID: 26039994
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan-mediated motility receptor confers resistance to chemotherapy
Zhang H; Ren L; Ding Y; Li F; Chen X; Ouyang Y; Zhang Y; Zhang D
FASEB J; 2019 May; 33(5):6365-6377. PubMed ID: 30802150
[TBL] [Abstract][Full Text] [Related]
14. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.
Guo Y; Cui W; Pei Y; Xu D
Gynecol Oncol; 2019 Jun; 153(3):639-650. PubMed ID: 30928020
[TBL] [Abstract][Full Text] [Related]
15. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
Wu YH; Chang TH; Huang YF; Huang HD; Chou CY
Oncogene; 2014 Jun; 33(26):3432-40. PubMed ID: 23934190
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor β pathway in pancreatic cancer via the TFCP2-SMAD2 axis.
Cai H; Guo F; Wen S; Jin X; Wu H; Ren D
J Exp Clin Cancer Res; 2022 Feb; 41(1):73. PubMed ID: 35193647
[TBL] [Abstract][Full Text] [Related]
17. Cytidine monophosphate kinase is inhibited by the TGF-β signalling pathway through the upregulation of miR-130b-3p in human epithelial ovarian cancer.
Zhou D; Zhang L; Sun W; Guan W; Lin Q; Ren W; Zhang J; Xu G
Cell Signal; 2017 Jul; 35():197-207. PubMed ID: 28414100
[TBL] [Abstract][Full Text] [Related]
18. The Overexpression of Keratin 23 Promotes Migration of Ovarian Cancer via Epithelial-Mesenchymal Transition.
Ren M; Gao Y; Chen Q; Zhao H; Zhao X; Yue W
Biomed Res Int; 2020; 2020():8218735. PubMed ID: 33204716
[TBL] [Abstract][Full Text] [Related]
19. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract][Full Text] [Related]
20. CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling.
Ying Z; Tian H; Li Y; Lian R; Li W; Wu S; Zhang HZ; Wu J; Liu L; Song J; Guan H; Cai J; Zhu X; Li J; Li M
J Clin Invest; 2017 May; 127(5):1725-1740. PubMed ID: 28375158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
